Autoimmune neutropenia, hemolytic anemia, and reticulocytopenia in Hodgkin's disease.
D000328:Adult; D000380:Agranulocytosis / Q000209:etiology*; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001327:Autoimmune Diseases / Q000209:etiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004906:Erythrocyte Count; D006689:Hodgkin Disease / Q000097:blood / Q000150:complications* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D009503:Neutropenia / Q000209:etiology* / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012156:Reticulocytes / Q000473:pathology*; D014750:Vincristine / Q000627:therapeutic use
D007074:Immunoglobulin G; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone